Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 166
Infectious Diseases Drugs 125
Genomics 102
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 60
Drug Discovery 55
Pharmaceuticals 53
Cardiovascular Drugs 47
Biopharmaceuticals 44
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Respiratory Drugs 29
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Pulmonary Medicine 23
Oncology 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 19
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Women's Health 7
Drugs by Therapeutic Area 6
Company Reports 5
Hepatology 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Generic Drugs 3
Prostate Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,042 Results (Page 45 of 53)
- Relevance
  Sort by

Recombinant DNA Technology Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Antibody-drug Conjugates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
200 Pages
Global

From

€4242EUR$4,750USD£3,713GBP

Cell Therapy Technologies Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Cell and Gene Therapy Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Orphan Drugs Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immunotherapy Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4242EUR$4,750USD£3,713GBP

Neoantigen Targeted Therapies Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Drugs for Immunotherapy Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Checkpoint Inhibitors Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

TNF Alpha Inhibitors Market Report 2025

 Report
April 2025
175 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Polycythemia Vera Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
99 Pages
Global

From

€3500EUR$4,198USD£3,171GBP

Viral RNA Polymerase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€893EUR$1,000USD£782GBP

€1116EUR$1,250USD£977GBP

Epigenetics Market Report 2025

 Report
January 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Germ Cell Tumor Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Appendiceal Cancer Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Small Molecule API Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Artificial Intelligence (AI) in Drug Discovery Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2032

 Drug Pipelines
June 2025
150 Pages
Global

From

€2679EUR$3,000USD£2,345GBP

€3349EUR$3,750USD£2,931GBP

Targeted Therapy Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€893EUR$1,000USD£782GBP

€1116EUR$1,250USD£977GBP

1,042 Results (Page 45 of 53)
- 1
- 43
- 44
- 45
- 46
- 47

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.